US stock futures dip as Nvidia earnings spark little cheer
Investing.com - MEI Pharma reported on Thursday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
MEI Pharma announced earnings per share of $-0.21 on revenue of $-603K. Analysts polled by Investing.com EPS of $-0.1925 on revenue of $4.78M.
MEI Pharma 's are down 11% and is trading at $0.527 , still down 85.15% from its 52 week high of $3.55 set on Tuesday, November 30, 2021.
MEI Pharma follows other major Healthcare sector earnings this month
MEI Pharma's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of $1.13 on revenue of $7.37B, EPS of $1.12 on revenue of $7.22B.
Agilent Technologies had beat expectations on Tuesday, August 16, 2022 with third quarter EPS of $1.34 on revenue of $1.72B, for EPS of $1.2 on revenue of $1.64B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar